Join our upcoming MPE and ASCERTAIN webinar on cost-effectiveness analysisMPE, Myeloma23 September 2025
Shape your myeloma care: New MPE research highlights the power of shared decision-making in myeloma careMPE, Myeloma, Patient evidence2 September 2025
The European Commission grants final authorisation for isatuximab (Sarclisa®) for transplant eligible newly diagnosed myeloma patientsMPE25 July 2025
Register now to join the webinar ‘How do different countries make decisions on reimbursing new medicines?’Access, MPE6 March 2025
